Fresenius Medical Care Starts €600 Million Buyback Under €1 Billion Program
FMS•Fresenius Medical Care initiated the first tranche of its EUR1 billion share buyback program, repurchasing up to EUR600 million by December 15, 2026. The AGM-approved plan underlines a disciplined capital allocation framework alongside dividends to enhance shareholder value.
1. First Tranche Launch
Fresenius Medical Care launched the initial phase of its share repurchase program today, earmarking up to EUR600 million for buybacks. The company expects to complete this tranche by December 15, 2026.
2. Authorization and Program Scope
The share buyback initiative forms part of a broader EUR1 billion program approved by shareholders at the Annual General Meeting on May 21, 2026. Under this authorization, Fresenius Medical Care may acquire treasury shares to support capital management objectives.
3. Strategic Capital Allocation
The buyback complements the company’s dividend policy and reflects a disciplined approach to capital deployment aimed at boosting earnings per share and returning value to investors.
